A Text-Based Smoking Cessation Intervention for Sexual and Gender Minority Groups: Protocol for a Feasibility Trial.
A Text-Based Smoking Cessation Intervention for Sexual and Gender Minority Groups: Protocol for a Feasibility Trial.
复制标题
DOI：
10.2196/42553
复制
发表时间：
2022-12-09
影响因子：
1.7
通讯作者：
Abroms, Lorien C
中科院分区：
文献类型：
--
作者：
Tami-Maury, Irene;Klaff, Rebecca;Hussin, Allison;Smith, Nathan Grant;Chang, Shine;McNeill, Lorna;Reitzel, Lorraine R;Shete, Sanjay;Abroms, Lorien C
据报道，吸烟在性少数群体（SGM）中非常普遍，其中包括女同性恋、男同性恋、双性恋、跨性别者和酷儿个体。这是由于多种因素造成的，包括少数族裔特有的压力和有针对性的烟草营销。因此，这一人群患烟草相关疾病的风险增加。人们发现短信计划对于戒烟非常有效，并且比其他干预措施更能吸引传统上难以接触到的人群。还有人建议，有针对性和量身定制的干预措施对 SGM 吸烟者可能更有效，因为这些干预措施旨在确保一个安全、有效的医疗保健环境，从而增强戒烟的接受度。本研究的目的是开发 SmokefreeSGM，这是一种针对 SGM 吸烟者量身定制并在 SGM 吸烟者中进行测试的基于文本的戒烟计划。该研究分为三个阶段，最终进行可行性试验。在第一阶段，我们的研究团队将与社区咨询委员会合作开发和预测试 SmokefreeSGM 的设计。在第二阶段，定制的短信程序将在 16 名 SGM 吸烟者中进行测试。我们的研究团队将使用混合方法来收集和分析参与者的数据，这些数据将为 SmokefreeSGM 的改进提供信息。在第三阶段，将在 80 名 SGM 吸烟者中进行可行性试验，这些吸烟者要么参加 SmokefreeSGM，要么参加 SmokefreeTXT，这是美国国家癌症研究所为普通人群开发的基于文本的原始程序。我们的研究团队将在 1、3 和 6 个月的随访中检查招募率、保留率和戒烟率。此外，还将对 32 名参与者进行定性访谈，以评估这些计划（SmokefreeSGM 和 SmokefreeTXT）的可行性和可接受性。这项研究获得德克萨斯大学休斯顿健康科学中心人类受试者保护委员会的批准，于 2020 年 8 月 21 日开始研究。SmokefreeSGM（第 2 阶段）的 beta 测试招募于 2022 年 1 月开始。我们估计可行性试验（第 3 阶段）将于 2022 年 9 月开始，结果将于 2023 年 12 月公布。这项研究工作的结果将有助于减少烟草相关的健康差异SGM 吸烟者通过确定 SmokefreeSGM（SGM 量身定制的戒烟干预措施）的可行性和可接受性。 ClinicalTrials.gov NCT05029362； https://clinicaltrials.gov/ct2/show/NCT05029362 DERR1-10.2196/42553
Smoking among sexual and gender minority (SGM) groups, which include lesbian, gay, bisexual, transgender, and queer individuals, has been reported to be highly prevalent. This is attributed to several factors, including minority-specific stress and targeted tobacco marketing. Therefore, this population is at an increased risk for tobacco-related diseases. SMS text messaging programs have been found to be effective for smoking cessation and appeal to traditionally hard-to-reach populations over other interventions. It has also been suggested that targeted and tailored interventions could be more effective among SGM smokers because they can be designed to assure a safe, validating health care environment that enhances receptivity to cessation. The aim of this study is to develop SmokefreeSGM, a text-based smoking cessation program tailored to and tested among SGM smokers. The study consists of three phases, culminating in a feasibility trial. In Phase 1, our research team will collaborate with a Community Advisory Board to develop and pretest the design of SmokefreeSGM. In Phase 2, the tailored text messaging program will be beta tested among 16 SGM smokers. Our research team will use a mixed-methods approach to collect and analyze data from participants who will inform the refinement of SmokefreeSGM. In Phase 3, a feasibility trial will be conducted among 80 SGM smokers either enrolled in SmokefreeSGM or SmokefreeTXT, the original text-based program developed by the National Cancer Institute for the general population. Our research team will examine recruitment, retention, and smoking abstinence rates at 1-, 3-, and 6-month follow-up. Additionally, a qualitative interview will be conducted among 32 participants to evaluate the feasibility and acceptability of the programs (SmokefreeSGM and SmokefreeTXT). This study received approval from The University of Texas Health Science Center at Houston Committee for the Protection of Human Subjects to begin research on August 21, 2020. Recruitment for the beta testing of SmokefreeSGM (Phase 2) began in January 2022. We estimate that the feasibility trial (Phase 3) will begin in September 2022 and that results will be available in December 2023. Findings from this research effort will help reduce tobacco-related health disparities among SGM smokers by determining the feasibility and acceptability of SmokefreeSGM, an SGM-tailored smoking cessation intervention. ClinicalTrials.gov NCT05029362; https://clinicaltrials.gov/ct2/show/NCT05029362 DERR1-10.2196/42553